Medpace Holdings, Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent
Medpace Holdings, Inc. (MEDP) reported Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent of 0.00% for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-16.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign · last filed 2021-02-16
- Medpace Holdings, Inc. effective income tax rate reconciliation, tax credit, foreign, percent for fiscal 2020 was 0.00%.
- Medpace Holdings, Inc. effective income tax rate reconciliation, tax credit, foreign, percent for fiscal 2019 was 0.00%, a 100.00% decline from fiscal 2018.
- Medpace Holdings, Inc. effective income tax rate reconciliation, tax credit, foreign, percent for fiscal 2018 was 0.80%.
- Medpace Holdings, Inc. effective income tax rate reconciliation, tax credit, foreign, percent for fiscal 2017 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent 12 month |
|---|---|
| 2020-12-31 | 0.00% 10-K · filed 2021-02-16 |
| 2019-12-31 | 0.00% 10-K · filed 2021-02-16 |
| 2018-12-31 | 0.80% 10-K · filed 2021-02-16 |
| 2017-12-31 | 0.00% 10-K · filed 2020-02-25 |
| 2016-12-31 | 0.00% 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |